2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

Data Compilation
#PharmaFlow

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

Stock Recap
#PipelineProspector

Riboflavin 5 Phosphate Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 6 USDMF, 1 CEP/COS, 5 JDMF, 4 EU WC, 7 NDC API, 5 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 13 FDA Orange Book, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 6 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 4 BASF, 1 Bioplus Life Sciences, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 3 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 8 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders, 19 Parenteral, 17 Solubilizers, 15 Taste Masking, 14 Film Formers & Plasticizers, 11 Chewable & Orodispersible Aids, 11 Topical, 10 Direct Compression, 9 Thickeners and Stabilizers, 8 Coating Systems & Additives, 8 Empty Capsules, 5 Emulsifying Agents, 4 Co-Processed Excipients, 4 Surfactant & Foaming Agents, 3 Disintegrants & Superdisintegrants, 3 Granulation, 2 API Stability Enhancers, 2 Coloring Agents, 1 Rheology Modifiers, 1 Controlled & Modified Release, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

MARKET PLACE

9 APIs, 1 EXCIPIENTS

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
26/09/2024	Supriya Lifescience	India	SUPRIYA LIFESCIENCE LTD	27005	RIBOFLAVIN 5' - PHOSPHATE SODIUM	2013-03-02	Active	II	N/A
26/09/2024	Curia	U.S.A	CURIA WISCONSIN INC	27188	RIBOFLAVIN 5'-PHOSPHATE SODIUM	2013-09-13	Active	II	N/A

List of Drug Master Files (DMF) of RIBOFLAVIN 5-PHOSPHATE SODIUM Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Riboflavin 5 Phosphate Sodium

Riboflavin 5 Phosphate Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers

6 USDMF

1 CEP/COS

5 JDMF

4 EU WC

7 NDC API

5 Listed Suppliers

$ API Reference Price

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers

13 FDA Orange Book

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

13 SPI Pharma

6 DKSH

1 Jai Radhe Sales

1 Pharm-RX Chemical

2 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

6 Actylis

4 BASF

1 Bioplus Life Sciences

2 Finar

6 Gangwal Chemicals

1 Ingredion Pharma Solutions

3 Kerry

3 Lonza Capsugel

2 Microlex e.U

1 Nanjing Bold Chemical

3 Pluviaendo

1 Qualicaps

14 Roquette

8 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders

19 Parenteral

17 Solubilizers

15 Taste Masking

14 Film Formers & Plasticizers

11 Chewable & Orodispersible Aids

11 Topical

10 Direct Compression

9 Thickeners and Stabilizers

8 Coating Systems & Additives

8 Empty Capsules

5 Emulsifying Agents

4 Co-Processed Excipients

4 Surfactant & Foaming Agents

3 Disintegrants & Superdisintegrants

3 Granulation

2 API Stability Enhancers

2 Coloring Agents